Predictors of outcome for pemetrexed (Pem) in metastatic NSCLC (mNSCLC).

Overview

cited authors

Jones, Cortney Vanderbilt, Du, Lingling, Elson, Paul, Mekhail, Tarek, Pennell, Nathan A., Sadraei, Nooshin Hashemi

authors

Mekhail, Tarek M., MD

Publication Date

May 20, 2013

webpage

Web of Science

published in

JOURNAL OF CLINICAL ONCOLOGY Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.